Experiment: 2M1N

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	500 mM [U-13C; U-15N; U-2H], 13CH3-Ala, Ile, Val, Leu CesAB (Type III secretion system, chaperone for EspA and EspB)	93% H2O/7% D2O	0.3	6.5	ambient	321
2	2D 1H-13C HSQC aliphatic	500 mM [U-13C; U-15N; U-2H], 13CH3-Ala, Ile, Val, Leu CesAB (Type III secretion system, chaperone for EspA and EspB)	93% H2O/7% D2O	0.3	6.5	ambient	321
3	3D HNCO	500 mM [U-13C; U-15N; U-2H], 13CH3-Ala, Ile, Val, Leu CesAB (Type III secretion system, chaperone for EspA and EspB)	93% H2O/7% D2O	0.3	6.5	ambient	321
4	3D HNCA	500 mM [U-13C; U-15N; U-2H], 13CH3-Ala, Ile, Val, Leu CesAB (Type III secretion system, chaperone for EspA and EspB)	93% H2O/7% D2O	0.3	6.5	ambient	321
5	3D HNCACB	500 mM [U-13C; U-15N; U-2H], 13CH3-Ala, Ile, Val, Leu CesAB (Type III secretion system, chaperone for EspA and EspB)	93% H2O/7% D2O	0.3	6.5	ambient	321
6	3D CBCA(CO)NH	500 mM [U-13C; U-15N; U-2H], 13CH3-Ala, Ile, Val, Leu CesAB (Type III secretion system, chaperone for EspA and EspB)	93% H2O/7% D2O	0.3	6.5	ambient	321
7	3D 1H-15N NOESY	500 mM [U-13C; U-15N; U-2H], 13CH3-Ala, Ile, Val, Leu CesAB (Type III secretion system, chaperone for EspA and EspB)	93% H2O/7% D2O	0.3	6.5	ambient	321
8	3D HMQC-NOESY-HMQC	500 mM [U-13C; U-15N; U-2H], 13CH3-Ala, Ile, Val, Leu CesAB (Type III secretion system, chaperone for EspA and EspB)	93% H2O/7% D2O	0.3	6.5	ambient	321

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	700

NMR Refinement
Method	Details	Software
simulated annealing		CNS

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	200
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure solution	CNS		Brunger, Adams, Clore, Gros, Nilges and Read
2	refinement	CNS		Brunger, Adams, Clore, Gros, Nilges and Read

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.